+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Thiazoles 5325-20-2
5325-20-2,MFCD00006698
Catalog No.:AA003HA3

5325-20-2 | 2,4-Dihydro-1,4-benzothiazin-3-one

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$11.00   $8.00
- +
5g
98%
in stock  
$34.00   $24.00
- +
25g
98%
in stock  
$87.00   $61.00
- +
100g
98%
in stock  
$286.00   $200.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003HA3
Chemical Name:
2,4-Dihydro-1,4-benzothiazin-3-one
CAS Number:
5325-20-2
Molecular Formula:
C8H7NOS
Molecular Weight:
165.2123
MDL Number:
MFCD00006698
SMILES:
O=C1CSc2c(N1)cccc2
NSC Number:
130
Properties
Properties
 
BP:
475.3°C at 760 mmHg  
Form:
Solid  
MP:
176-178 °C(lit.)  
Refractive Index:
1.6458 (estimate)  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
172  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
XLogP3:
1.4  

Downstream Synthesis Route

[1]Patent:US2003/229026,2003,A1.Locationinpatent:Page21

[2]ArchivderPharmazie,1999,vol.332,p.19-24

[3]AustralianJournalofChemistry,1955,vol.8,p.252,255

[4]Farmaco,EdizioneScientifica,1985,vol.40,p.369-376

[5]Patent:US2008/305169,2008,A1

[6]Patent:US2007/10670,2007,A1.Locationinpatent:Page/Pagecolumn82

[7]Patent:US2008/64871,2008,A1.Locationinpatent:Page/Pagecolumn45

[1]ArchivderPharmazie,1999,vol.332,p.19-24

[2]MonatsheftefurChemie,1907,vol.28,p.271

[3]ChemischeBerichte,1912,vol.45,p.751    ChemischesZentralblatt,1913,vol.84,p.865

[4]Patent:DE256342,    Fortschr.Teerfarbenfabr.Verw.Industriezweige,vol.11,p.160

[5]JournaloftheChemicalSocietyC:Organic,1971,p.1718-1721

[6]ComptesRendusdesSeancesdel'AcademiedesSciences,SerieC:SciencesChimiques,1971,vol.273,p.1378-1381

[7]CanadianJournalofChemistry,1966,vol.44,p.1733-1741

[1]Venkatesh,Ramineni;Kasaboina,Suresh;Bidayat,Deepthi;NikhilKumar;Jain,Nishant;Tangeda,SarithaJostna;Bantu,Rajashaker;Janardhan,Sridhara;Nagarapu,Lingaiah[BioorganicandMedicinalChemistryLetters,2017,vol.27,#2,p.354-359]

[2]Locationinpatent:experimentalpartGowda;Khader;Kalluraya;Shree,Padma;Shabaraya[EuropeanJournalofMedicinalChemistry,2011,vol.46,#9,p.4100-4106]

[3]Hofmann,A.W.[ChemischeBerichte,1880,vol.13,p.1236]Unger[ChemischeBerichte,1897,vol.30,p.608]Langlet[BihangtillSvenskaVet.-Akad.Handlingar22II,No.1,S.10]

[4]Trapani,G.;Reho,A.;Morlacchi,F.;Latrofa,A.;Marchini,P.;etal.[Farmaco,EdizioneScientifica,1985,vol.40,#5,p.369-376]

[5]Shaikh,MubarakH.;Subhedar,DnyaneshwarD.;Arkile,Manisha;Khedkar,VijayM.;Jadhav,Nandadeep;Sarkar,Dhiman;Shingate,BapuraoB.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#2,p.561-569]

[1]Shaikh,MubarakH.;Subhedar,DnyaneshwarD.;Arkile,Manisha;Khedkar,VijayM.;Jadhav,Nandadeep;Sarkar,Dhiman;Shingate,BapuraoB.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#2,p.561-569]

[2]Rajender;Narsimha;Reddy,N.Vasudeva[AsianJournalofChemistry,2019,vol.31,#11,p.2647-2652]

[3]Prasad,R.N.;Tietje,K.[CanadianJournalofChemistry,1966,vol.44,p.1247-1258]

[4]Walser;Flynn;Mason;Crowley;Maresca;Yaremko;O'Donnell[JournalofMedicinalChemistry,1991,vol.34,#3,p.1209-1221]

[5]PavanKumar,Ch.;Devi;AshokYadav;RaoVadaparthi;Shankaraiah;Sowjanya;Jain,Nishant;SureshBabu[JournalofAsianNaturalProductsResearch,2016,vol.18,#11,p.1063-1078]

[1]Huang,Zhi-Zhen;Zu,Liu-Sheng[OrganicPreparationsandProceduresInternational,1996,vol.28,#1,p.121-123]

[2]Maheshwari,Monika;Yadav,Mithlesh;Pathak,Devendra[IndianJournalofHeterocyclicChemistry,2010,vol.20,#2,p.145-148]

[3]Worley,J.W.etal.[JournalofOrganicChemistry,1975,vol.40,p.1731-1734]

[4]Ambrogi,V.;Grandolini,G.;Perioli,L.;Ricci,M.;Rossi,C.;Tuttobello,L.[EuropeanJournalofMedicinalChemistry,1990,vol.25,#5,p.403-411]

[5]CurrentPatentAssignee:MitsubishiChemicalCorp(in:MCHCGroup);MITSUBISHICHEMICALHOLDINGSCORPORATION-EP2302003,2011,A1Locationinpatent:Page/Pagecolumn27-28

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Title: Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents.

Journal: Bioorganic & medicinal chemistry letters 20100115

Title: 2-(4-Chloro-benzoyl-meth-yl)-2H-1,4-benzothia-zin-3(4H)-one.

Journal: Acta crystallographica. Section E, Structure reports online 20080401

Title: Benzofused tricycles based on 2-quinoxalinol.

Journal: Journal of combinatorial chemistry 20070101

Title: Parallel solution-phase synthesis of 4H-benzo[1,4]thiazin-3-one and 1,1-dioxo-1,4-dihydro-2H-1lambda6-benzo[1,4]thiazin-3-one derivatives from 1,5-difluoro-2,4-dinitrobenzene.

Journal: Journal of combinatorial chemistry 20070101

Title: Design and synthesis of novel tricycles based on 4H-benzo[1,4]thiazin-3-one and 1,1-dioxo-1,4-dihydro-2H-1lambda6-benzo[1,4]thiazin-3-one.

Journal: Journal of combinatorial chemistry 20070101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 5325-20-2
30322-02-2

30322-02-2

 3080-99-7

3080-99-7

 90814-91-8

90814-91-8

 5333-05-1

5333-05-1

 21762-78-7

21762-78-7

 139605-34-8

139605-34-8
Building Blocks
More >
Tags:5325-20-2 Molecular Formula|5325-20-2 MDL|5325-20-2 SMILES|5325-20-2 2,4-Dihydro-1,4-benzothiazin-3-one |Organic_Building_Blocks